12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Biomarin Pharmaceutical Inc (BMRN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Viking Global Andreas Halvorsen | 10,510,550 | $690,858,452 | +8% | 2.23% |
| 2. | Elliott Management Paul Singer | 3,500,338 | $230,077,217 | 1.37% | |
| 3. | VenBio Select Advisor Kurt Von Emster | 1,462,500 | $96,130,125 | -29% | 1.35% |
| 4. | AQR Capital Management Cliff Asness | 1,283,599 | $84,370,933 | +115% | 0.1% |
| 5. | Palo Alto Investors William Leland Edwards | 1,067,266 | $70,151,394 | -3% | 10.86% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $86.75 | 3,625 | Director | 10,905 | 2022-10-31 | Filing | |
| $78.84 | 900 | Director | 30,740 | 2020-08-31 | Filing | |
| $78.22 | 11,900 | Director | 29,840 | 2020-08-31 | Filing | |
| $21.76 | 161 | Officer | 100,574 | 2012-10-31 | Filing | |
| $21.76 | 548 | Officer | 15,294 | 2012-10-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.37 | 5,278 | Officer | 68,909 | 2024-11-12 | Filing | |
| $90.00 | 714 | Officer | 14,449 | 2024-08-13 | Filing | |
| $75.19 | 5,000 | Officer | 72,159 | 2024-05-30 | Filing | |
| $75.29 | 2,779 | Officer | 56,157 | 2024-05-28 | Filing | |
| $74.46 | 38,071 | Officer | 58,936 | 2024-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,513,116 | $1,545,517,113 | 0.03% | |
| 2. | 19,372,185 | $1,273,333,721 | 0.02% | |
| 3. | 18,189,171 | $1,195,574,211 | 0.92% | |
| 4. | 14,746,235 | $969,270,027 | 0.56% | |
| 5. | 12,991,772 | $853,944,202 | 0.17% |
News See All
12 Best Depressed Stocks to Invest in Now
The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily aided by solid economic growth, healthy earnings momentum, and the expectations of the rate cuts.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Under-the-Radar Stocks with Massive Upside for 2025
Investing in under-the-radar stocks can be a savvy move for those looking to diversify their portfolios and potentially reap significant rewards.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The U.S.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Bailey and I will be your conference operator today.
10 Best Falling Stocks To Buy According to Hedge Funds
Analysts at Goldman Sachs on October 21st released a note forecasting that the S&P 500 average annual return of 13% for the past 10 years might come down to just 3% for the next decade.